Patients with scans without evidence of dopaminergic deficit: A long-term follow-up study

Movement Disorders

Volumn 29, Issue 14, 2014, Pages 1820-1825

  Batla, Amit ^a   Erro, Roberto ^a   Stamelou, Maria ^a,b,c   Schneider, Susanne A ^d   Schwingenschuh, Petra ^e   Ganos, Christos ^a   Bhatia, Kailash P ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF ATHENS   (Greece)

^c PHILIPPS UNIVERSITY MARBURG   (Germany)

^d UNIVERSITY OF KIEL   (Germany)

^e MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

DaTscan; Dopamine; Dystonia; Dystonic tremor; Parkinson's disease; SWEDD

Indexed keywords

DOPAMINE; DOPAMINE TRANSPORTER;

ADULT; AGED; DYSTONIC DISORDERS; FEMALE; FOLLOW UP; HUMAN; MALE; METABOLISM; MIDDLE AGED; PARKINSON DISEASE; PATHOPHYSIOLOGY; PROCEDURES; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TIME; TREMOR; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DYSTONIC DISORDERS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; TIME; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TREMOR;

EID: 84918518903     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.26018     Document Type: Article

References (27)

1. Parkinson Study Group. A randomized controlled trial comparing pramipexole with levodopa in early Parkinson's disease: design and methods of the CALM-PD Study. Clin Neuropharmacol 2000;23:34-44.
2. Whone AL, Watts RL, Stoessl AJ, et al. Slower progression of Parkinson's disease with ropinirole versus levodopa: the REAL-PET study. Ann Neurol 2003;54:93-101.
3. Parkinson Study Group. Dopamine transporter brain imaging to assess the effects of pramipexole vs levodopa on Parkinson disease progression. JAMA 2002;287:1653-1661.
4. Sixel-Doring F, Liepe K, Mollenhauer B, Trautmann E, Trenkwalder C. The role of 123I-FP-CIT-SPECT in the differential diagnosis of Parkinson and tremor syndromes: a critical assessment of 125 cases. J Neurol 2011;258:2147-2154.
5. Benamer HT, Oertel WH, Patterson J, et al. Prospective study of presynaptic dopaminergic imaging in patients with mild parkinsonism and tremor disorders: part 1. Baseline and 3-month observations. Mov Disord 2003;18:977-984.
6. Hall DA, Jennings D, Seibyl J, Tassone F, Marek K. FMR1 gene expansion and scans without evidence of dopaminergic deficits in parkinsonism patients. Parkinsonism Relat Disord 2010;16:608-611.
7. Schneider SA, Edwards MJ, Mir P, et al. Patients with adult-onset dystonic tremor resembling parkinsonian tremor have scans without evidence of dopaminergic deficit (SWEDDs). Mov Disord 2007;22:2210-2215.
8. Silveira-Moriyama L, Schwingenschuh P, O'Donnell A, et al. Olfaction in patients with suspected parkinsonism and scans without evidence of dopaminergic deficit (SWEDDs). J Neurol Neurosurg Psychiatry 2009;80:744-748.
9. Schwingenschuh P, Ruge D, Edwards MJ, et al. Distinguishing SWEDDs patients with asymmetric resting tremor from Parkinson's disease: a clinical and electrophysiological study. Mov Disord 2010;25:560-569.
10. Morrish P. The meaning of negative DAT SPECT and F-Dopa PET scans in patients with clinical Parkinson's disease. Mov Disord 2005;20:117; author reply, 117-118.
11. Marek K, Jennings D, Seibyl J. Long-term follow-up of patients with scans without evidence of dopaminergic deficit (SWEDD) in the ELLDOPA study. Neurology 2005;64(Suppl 1):A274.
12. Sommer U, Hummel T, Cormann K, et al. Detection of presymptomatic Parkinson's disease: combining smell tests, transcranial sonography, and SPECT. Mov Disord 2004;19:1196-1202.
13. Bezard E, Dovero S, Prunier C, et al. Relationship between the appearance of symptoms and the level of nigrostriatal degeneration in a progressive 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-lesioned macaque model of Parkinson's disease. J Neurosci 2001;21:6853-6861.
14. Kagi G, Bhatia KP, Tolosa E. The role of DAT-SPECT in movement disorders. J Neurol Neurosurg Psychiatry 2010;81:5-12.
15. Ross GW, Petrovitch H, Abbott RD, et al. Parkinsonian signs and substantia nigra neuron density in decendents elders without PD. Ann Neurol 2004;56:532-539.
16. Minen MT, Louis ED. Emergence of Parkinson's disease in essential tremor: a study of the clinical correlates in 53 patients. Mov Disord 2008;23:1602-1605.
17. Chaudhuri KR, Buxton-Thomas M, Dhawan V, Peng R, Meilak C, Brooks DJ. Long duration asymmetrical postural tremor is likely to predict development of Parkinson's disease and not essential tremor: clinical follow up study of 13 cases. J Neurol Neurosurg Psychiatry 2005;76:115-117.
18. Wolters A, Walter U, Wittstock M, Benecke R. Asymmetric postural tremor preceding DOPA-responsive parkinsonism-the transition disease. J Parkinsons Dis 2014;4:45-55.
19. Katchen M, Duvoisin RC. Parkinsonism following dystonia in three patients. Mov Disord 1986;1:151-157.
20. Papapetropoulos S, Singer C. Cervical dystonia as a presenting symptom of Parkinson's disease. Parkinsonism Relat Disord 2006;12:514-516.
21. Josephs KA, Matsumoto JY, Ahlskog JE. Benign tremulous parkinsonism. Arch Neurol 2006;63:354-357.
22. Selikhova M, Kempster PA, Revesz T, Holton JL, Lees AJ. Neuropathological findings in benign tremulous parkinsonism. Mov Disord 2013;28:145-152.
23. 123I]FP-CIT-SPET binding in Parkinson's disease. Neurol Sci 2006;27:397-401.
24. Sossi V, de la Fuente-Fernandez R, Schulzer M, Troiano AR, Ruth TJ, Stoessl AJ. Dopamine transporter relation to dopamine turnover in Parkinson's disease: a positron emission tomography study. Ann Neurol 2007;62:468-474.
25. 123I]FP-CIT SPECT in early-onset parkin disease. Neurology 2004;63:2097-2103.
26. 123I]-beta-CIT demonstrates presynaptic nigrostriatal dopaminergic damage in Wilson's disease. J Neurol Neurosurg Psychiatry 1998;65:60-64.
27. 123I]ss-CIT and high-resolution SPET. Eur J Nucl Med 2001;28:1656-1663.